Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
GHRS
Stock Latest News
Company Announcements
GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy
3h ago
6K
GHRS
Premium
The Fly
GH Research announces publication of Phase 2b results for mebufotenin
4h ago
GHRS
Premium
Company Announcements
GH Research to Join Stifel 2026 Virtual CNS Forum Fireside Chat
9d ago
6K
GHRS
Premium
Ratings
GH Research: Advancing GH001 Toward 2026 Pivotal Phase 3 in Treatment-Resistant Depression With Favorable Risk-Reward and $70 Target
13d ago
GHRS
Premium
The Fly
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
13d ago
ATAI
CMND
Premium
The Fly
GH Research price target raised to $34 from $29 at Guggenheim
15d ago
GHRS
Premium
Ratings
GH Research: Advancing Phase 3 TRD Program Post‑Hold with Strong Cash Runway Supports Buy Rating
17d ago
GHRS
Premium
The Fly
GH Research price target raised to $42 from $39 at Citizens
19d ago
GHRS
Premium
Ratings
GH Research: Phase 3 Readiness, Expanding Indications, and Valuation Upside Reinforce Buy Rating
20d ago
GHRS
Premium
The Fly
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
20d ago
PBM
ATAI
Premium
Company Announcements
GH Research Posts 2025 Results as TRD Drug GH001 Clears Key Phase 2b Milestone
20d ago
6K
GHRS
Premium
The Fly
GH Research reports FY25 EPS (79c), consensus (82c)
20d ago
GHRS
Premium
The Fly
Psychedelic: Analyst raises Compass, Definium, GH Research price targets
2M ago
PBM
CMPS
Premium
The Fly
GH Research price target raised to $40 from $33 at RBC Capital
2M ago
GHRS
Premium
Company Announcements
GH Research to Present at RBC Capital Markets Psychedelics Symposium
2M ago
6K
GHRS
Premium
Company Announcements
GH Research Showcases GH001 Depression Data at ACNP 2026 Mini‑Panel
2M ago
6K
GHRS
Premium
Company Announcements
GH Research Showcases Positive GH001 Phase 2b Data in Treatment-Resistant Depression at ACNP 2026
2M ago
6K
GHRS
Premium
The Fly
Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
3M ago
CMPS
DRUG
Premium
Company Announcements
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting
3M ago
6K
GHRS
Premium
The Fly
GH Research price target raised to $29 from $19 at Needham
3M ago
GHRS
Premium
The Fly
GH Research price target raised to $39 from $35 at Canaccord
3M ago
GHRS
Premium
The Fly
Midday Fly By: U.S. oil majors rise on Venezuela news, Versant completes spinoff
3M ago
TM
ALT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
